Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure

NCT02580474 is registered in ClinicalTrials.gov with Myeong Jun Song as lead sponsor.

NCT NCT02580474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02580474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure
Lead sponsor
Myeong Jun Song
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2016
Completion date
April 30, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c